Survey of coronary catheterization laboratory activity in Iran during the coronavirus disease-2019 pandemic

Mohammad Kermani-Alghoraishi1, Ehsan Shirvani2, Alireza Khosravi3

  • 1Assistant Professor, Interventional Cardiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.

ARYA Atherosclerosis
|November 7, 2022
PubMed

Insights

COVID-19 significantly reduced coronary catheterization procedures in Iran. This decline in cardiac interventions may increase the risk of cardiovascular mortality and morbidity.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • The COVID-19 pandemic led to a global decrease in non-COVID patient hospitalizations and treatments.
  • Evaluating the impact on coronary artery disease (CAD) patient care is crucial.

Purpose of the Study:

  • To assess changes in the admission and treatment of CAD patients.
  • To analyze coronary catheterization laboratory (Cath lab) activity in Iran during the COVID-19 pandemic.

Main Methods:

  • A retrospective, multi-center study in Iran using data from the National Persian Registry Of CardioVascular diseasE (N-PROVE).
  • Comparison of two COVID-19 peak periods with the same dates in 2019.
  • Data collected on diagnostic and therapeutic coronary catheterizations for stable ischemic heart diseases (SIHDs) and acute coronary syndrome (ACS).

Main Results:

  • Coronary angiography and angioplasty decreased by 37% and 38% during the first COVID-19 peak.
  • ACS, particularly STEMI, was the primary indication initially, shifting to SIHDs during peak decreases.
  • The second peak saw a 34% and 27% reduction in diagnostic and therapeutic procedures, respectively.
  • Elective admissions rose but remained below 2019 levels; rescue PCI increased.

Conclusions:

  • A significant reduction in coronary Cath lab activity occurred during the COVID-19 pandemic.
  • This decrease may correlate with an elevated risk of cardiovascular mortality and morbidity.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
22
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
126
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
20
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
87
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
141